sglt2 inhibitors: can these drugs slow the progression of chronic kidney disease?
Published 1 year ago • 1.5K plays • Length 49:14Download video MP4
Download video MP3
Similar videos
-
9:06
sglt2 inhibitors in chronic kidney disease
-
15:35
field notes ep. 19 | slowing down progression of ckd - sglt2 inhibitors with dr. robert kossmann
-
8:15
sglt2 inhibitors and heart failure
-
16:24
how sglt2 inhibitors protect the kidney
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
11:01
why sglt2 inhibitors cause euglycemic dka
-
7:29
"connection of sglt2, dka and the kidney" by dr. manisha sahay
-
39:55
the current concepts of use of acei / arb, sglt2 inhibitors & finerenone in ckd |dr. ashok kirpalani
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
3:23
what are sglt2 inhibitors - chronic kidney disease | uhl nhs trust
-
35:24
professor david wheeler - 'how do sglt2 inhibitors benefit the kidney?'
-
32:00
role of sglt2 inhibitors in ckd
-
9:55
how sglt2 inhibitors protect the kidney in patients with diabetes mellitus?
-
58:38
nephrology grand rounds: sglt2 inhibitors
-
6:58
sglt2 inhibitors in t1d: 'people are using them now'
-
4:54
sglt 2 inhibitors a game changer | diabetes treatment | diabetes | kidney disease | kidney
-
1:05:08
new glucose-lowering drugs and kidney protection in ckd
-
30:05
professor david wheeler - renoprotective effects of sglt2 inhibitors
-
4:41
cv risk in t2d: role of sglt2 inhibition
-
1:05:21
sglt2 inhibitors in heart failure: new analyses and recent updates
-
28:56
christine limonte, md - update on sglt2i: real-world use and special population
-
1:00:55
sglt2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease